Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteins
- 1 January 1997
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 33 (1), 147-155
- https://doi.org/10.1016/s0008-6363(96)00199-x
Abstract
Objective: Reperfusion of the infarct-related artery in patients with acute myocardial infarction limits infarct size, but also causes accelerated release into plasma of cardiac tissue proteins. The latter effect could reflect either enhanced protein washout from the heart or abrupt disruption of myocyte membranes. The present study indicates that the latter mechanism prevails. Methods: In 26 patients, patency of the infarct-related artery was determined by coronary angiography 90 min and 5–7 days after thrombolytic treatment. Continuous electrocardiography was performed during the first 24 h after admission. Cumulative release of myoglobin (Mb) and creatine kinase (CK) into plasma was calculated from frequently sampled plasma concentrations. Results: In patients with a patent infarct-related artery after 90 min, the onset of a rapid (> 50%) decrease in ST-vector magnitude coincided with an equally rapid increase in QRS-vector magnitude, and with a sudden onset of release into plasma of Mb as well as CK. In these patients, a maximal initial release rate was observed and cumulative release conformed closely to a simple model for sudden interstitial liberation of proteins. In contrast, protein release started more gradually and could not be fitted to this model, in patients with persistent occlusion of the infarct-related artery at 90 min and absence of ST-vector normalisation. Conclusions: Previous studies have demonstrated significant myocardial salvage by timely reperfusion therapy. Nevertheless, this study indicates that the moment of recanalisation of the infarct-related artery coincides with sudden and massive disruption of myocyte membranes. Attenuation of this effect, if possible, could further improve the benefits of reperfusion therapy.Keywords
This publication has 27 references indexed in Scilit:
- Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans.Heart, 1994
- Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator.Circulation, 1990
- Does reperfusion extend necrosis? A study in a single territory of myocardial ischemia--half reperfused and half not reperfused.Circulation, 1990
- The role of neutrophils and free radicals in the ischemic-reperfused heart: Why the confusion and controversy?Journal of Molecular and Cellular Cardiology, 1989
- The role of the neutrophil and free radicals in ischemic myocardial injuryJournal of Molecular and Cellular Cardiology, 1989
- Effect of reperfusion on electrocardiographic and enzymatic infarct size: Results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarctionAmerican Heart Journal, 1988
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Myocardial reperfusion: a double-edged sword?Journal of Clinical Investigation, 1985
- Quantitative analysis of plasma enzyme levels based upon simultaneous determination of different enzymesCardiovascular Research, 1982
- HISTOCHEMICAL CHANGES IN THE MYOCARDIUM OF DOGS FOLLOWING EXPERIMENTAL TEMPORARY CORONARY ARTERIAL OCCLUSIONAmerican Journal of Physiology-Legacy Content, 1942